OIM
Oracle Investment Management’s Soleno Therapeutics SLNO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,132,000
| Closed | -$394K | – | 24 |
|
|
2022
Q2 | $394K | Hold |
2,132,000
| – | – | 0.12% | 21 |
|
|
2022
Q1 | $475K | Hold |
2,132,000
| – | – | 0.09% | 21 |
|
|
2021
Q4 | $874K | Hold |
2,132,000
| – | – | 0.12% | 18 |
|
|
2021
Q3 | $1.97M | Hold |
2,132,000
| – | – | 0.25% | 23 |
|
|
2021
Q2 | $2.43M | Hold |
2,132,000
| – | – | 0.33% | 23 |
|
|
2021
Q1 | $2.69M | Sell |
2,132,000
-1,538,384
| -42% | -$1.94M | 0.4% | 20 |
|
|
2020
Q4 | $7.08M | Hold |
3,670,384
| – | – | 0.89% | 11 |
|
|
2020
Q3 | $9.21M | Hold |
3,670,384
| – | – | 1.21% | 8 |
|
|
2020
Q2 | $8.15M | Sell |
3,670,384
-200,243
| -5% | -$445K | 1.03% | 9 |
|
|
2020
Q1 | $9.21M | Hold |
3,870,627
| – | – | 2.74% | 5 |
|
|
2019
Q4 | $11.4M | Hold |
3,870,627
| – | – | 2.14% | 6 |
|
|
2019
Q3 | $5.81M | Buy |
3,870,627
+57,069
| +1% | +$85.6K | 1.43% | 8 |
|
|
2019
Q2 | $10.7M | Hold |
3,813,558
| – | – | 2.3% | 7 |
|
|
2019
Q1 | $7.86M | Buy |
3,813,558
+130,363
| +4% | +$269K | 1.67% | 11 |
|
|
2018
Q4 | $6.3M | Buy |
3,683,195
+1,245,135
| +51% | +$2.13M | 1.95% | 10 |
|
|
2018
Q3 | $5.27M | Hold |
2,438,060
| – | – | 1.15% | 11 |
|
|
2018
Q2 | $5.71M | Buy |
2,438,060
+50,000
| +2% | +$117K | 1.38% | 11 |
|
|
2018
Q1 | $4.33M | Hold |
2,388,060
| – | – | 1.05% | 15 |
|
|
2017
Q4 | $4.3M | Buy |
+2,388,060
| New | +$4.3M | 0.85% | 14 |
|